Green tea EGCG suppresses T cell proliferation through impairment of IL-2/IL-2 receptor signaling

Free Radical Biology and Medicine

Volumn 47, Issue 5, 2009, Pages 636-643

  Wu, Dayong ^a   Guo, Zhuyan ^a   Ren, Zhihong ^a   Guo, Weimin ^a   Meydani, Simin Nikbin ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

EGCG; Green tea; Immune function; Interleukin 2; T cells

Indexed keywords

ALPHA TOCOPHEROL; CATALASE; EPIGALLOCATECHIN GALLATE; GAMMA INTERFERON; HYDROGEN PEROXIDE; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; AUTOIMMUNITY; CELL CULTURE; CELL CYCLE PROGRESSION; CELL DIVISION; CELL PROLIFERATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DIET SUPPLEMENTATION; DRUG ANTAGONISM; IMMUNE RESPONSE; INFLAMMATION; INHIBITION KINETICS; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SPLEEN CELL; T LYMPHOCYTE; TEA;

ANIMALS; CATECHIN; CELL CYCLE; CELL DIVISION; CELL PROLIFERATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; HYDROGEN PEROXIDE; INTERLEUKIN-2; MALE; MICE; MICE, INBRED C57BL; RECEPTORS, INTERLEUKIN-2; SIGNAL TRANSDUCTION; T-LYMPHOCYTES; TEA; VITAMIN E;

MUS;

EID: 67650747279     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2009.06.001     Document Type: Article

References (44)

1. Yang C.S., Maliakal P., and Meng X. Inhibition of carcinogenesis by tea. Annu. Rev. Pharmacol. Toxicol. 42 (2002) 25-54
2. Hofmann C.S., and Sonenshein G.E. Green tea polyphenol epigallocatechin-3 gallate induces apoptosis of proliferating vascular smooth muscle cells via activation of p53. FASEB J. 17 (2003) 702-704
3. Aktas O., Prozorovski T., Smorodchenko A., Savaskan N.E., Lauster R., Kloetzel P.M., Infante-Duarte C., Brocke S., and Zipp F. Green tea epigallocatechin-3-gallate mediates T cellular NF-kappa B inhibition and exerts neuroprotection in autoimmune encephalomyelitis. J. Immunol. 173 (2004) 5794-5800
4. Hu Z.Q., Toda M., Okubo S., Hara Y., and Shimamura T. Mitogenic activity of (-)epigallocatechin gallate on B-cells and investigation of its structure-function relationship. Int. J. Immunopharmacol. 14 (1992) 1399-1407
5. Wilasrusmee C., Kittur S., Siddiqui J., Bruch D., Wilasrusmee S., and Kittur D.S. In vitro immunomodulatory effects of ten commonly used herbs on murine lymphocytes. J. Altern. Complement. Med. 8 (2002) 467-475
6. Zvetkova E., Wirleitner B., Tram N.T., Schennach H., and Fuchs D. Aqueous extracts of Crinum latifolium (L.) and Camellia sinensis show immunomodulatory properties in human peripheral blood mononuclear cells. Int. Immunopharmacol. 1 (2001) 2143-2150
7. Ahn S.C., Kim G.Y., Kim J.H., Baik S.W., Han M.K., Lee H.J., Moon D.O., Lee C.M., Kang J.H., Kim B.H., Oh Y.H., and Park Y.M. Epigallocatechin-3-gallate, constituent of green tea, suppresses the LPS-induced phenotypic and functional maturation of murine dendritic cells through inhibition of mitogen-activated protein kinases and NF-kappaB. Biochem. Biophys. Res. Commun. 313 (2004) 148-155
8. Nakagawa K., Okuda S., and Miyazawa T. Dose-dependent incorporation of tea catechins, (-)-epigallocatechin-3-gallate and (-)-epigallocatechin, into human plasma. Biosci. Biotechnol. Biochem. 61 (1997) 1981-1985
9. Ullmann U., Haller J., Decourt J.P., Girault N., Girault J., Richard-Caudron A.S., Pineau B., and Weber P. A single ascending dose study of epigallocatechin gallate in healthy volunteers. J. Int. Med. Res. 31 (2003) 88-101
10. Lambert J.D., Lee M.J., Diamond L., Ju J., Hong J., Bose M., Newmark H.L., and Yang C.S. Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues. Drug Metab. Dispos. 34 (2006) 8-11
11. Adolfsson O., Huber B.T., and Meydani S.N. Vitamin E-enhanced IL-2 production in old mice: naive but not memory T cells show increased cell division cycling and IL-2-producing capacity. J. Immunol. 167 (2001) 3809-3817
12. Lee C.Y., and Man-Fan Wan J. Vitamin E supplementation improves cell-mediated immunity and oxidative stress of Asian men and women. J. Nutr. 130 (2000) 2932-2937
13. Meydani S.N., Han S.N., and Wu D. Vitamin E and immune response in the aged: molecular mechanisms and clinical implications. Immunol. Rev. 205 (2005) 269-284
14. Rezai-Zadeh K., Shytle D., Sun N., Mori T., Hou H., Jeanniton D., Ehrhart J., Townsend K., Zeng J., Morgan D., Hardy J., Town T., and Tan J. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J. Neurosci. 25 (2005) 8807-8814
15. Lee M.J., Maliakal P., Chen L., Meng X., Bondoc F.Y., Prabhu S., Lambert G., Mohr S., and Yang C.S. Pharmacokinetics of tea catechins after ingestion of green tea and (-)-epigallocatechin-3-gallate by humans: formation of different metabolites and individual variability. Cancer Epidemiol. Biomark. Prev. 11 (2002) 1025-1032
16. Kim S., Lee M.J., Hong J., Li C., Smith T.J., Yang G.Y., Seril D.N., and Yang C.S. Plasma and tissue levels of tea catechins in rats and mice during chronic consumption of green tea polyphenols. Nutr. Cancer 37 (2000) 41-48
17. Chai P.C., Long L.H., and Halliwell B. Contribution of hydrogen peroxide to the cytotoxicity of green tea and red wines. Biochem. Biophys. Res. Commun. 16 (2003) 650-654
18. Yang G.Y., Liao J., Li C., Chung J., Yurkow E.J., Ho C.T., and Yang C.S. Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis 21 (2000) 2035-2039
19. Furukawa A., Oikawa S., Murata M., Hiraku Y., and Kawanishi S. (-)-Epigallocatechin gallate causes oxidative damage to isolated and cellular DNA. Biochem. Pharmacol. 66 (2003) 1769-1778
20. Yang G.Y., Liao J., Kim K., Yurkow E.J., and Yang C.S. Inhibition of growth and induction of apoptosis in human cancer cell lines by tea polyphenols. Carcinogenesis 9 (1998) 611-616
21. Elbling L., Weiss R.M., Teufelhofer O., Uhl M., Knasmueller S., Schulte-Hermann R., Berger W., and Micksche M. Green tea extract and (-)-epigallocatechin-3-gallate, the major tea catechin, exert oxidant but lack antioxidant activities. FASEB J. 19 (2005) 807-809
22. Nam S., Smith D.M., and Dou Q.P. Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo. J. Biol. Chem. 276 (2001) 13322-13330
23. Smith D.M., Wang Z., Kazi A., Li L.H., Chan T.H., and Dou Q.P. Synthetic analogs of green tea polyphenols as proteasome inhibitors. Mol. Med. 8 (2002) 382-392
24. Lambert J.D., and Yang C.S. Mechanisms of cancer prevention by tea constituents. J. Nutr. 133 (2003) 3262S-3267S
25. Lin J.K., Liang Y.C., and Lin-Shiau S.Y. Cancer chemoprevention by tea polyphenols through mitotic signal transduction blockade. Biochem. Pharmacol. 58 (1999) 911-915
26. Yamamoto T., Lewis J., Wataha J., Dickinson D., Singh B., Bollag W.B., Ueta E., Osaki T., Athar M., Schuster G., and Hsu S. Roles of catalase and hydrogen peroxide in green tea polyphenol-induced chemopreventive effects. J. Pharmacol. Exp. Ther. 308 (2004) 317-323
27. Sah J.F., Balasubramanian S., Eckert R.L., and Rorke E.A. Epigallocatechin-3-gallate inhibits epidermal growth factor receptor signaling pathway. Evidence for direct inhibition of ERK1/2 and AKT kinases. J. Biol. Chem. 279 (2004) 12755-12762
28. Ahmad N., Adhami V.M., Gupta S., Cheng P., and Mukhtar H. Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate. Arch. Biochem. Biophys. 398 (2002) 125-131
29. Lea N.C., Orr S.J., Stoeber K., Williams G.H., Lam E.W., Ibrahim M.A., Mufti G.J., and Thomas N.S. Commitment point during G0->G1 that controls entry into the cell cycle. Mol. Cell. Biol. 23 (2003) 2351-2361
30. Firpo E.J., Koff A., Solomon M.J., and Roberts J.M. Inactivation of a Cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell. Biol. 14 (1994) 4889-4901
31. Nelson B.H., and Willerford D.M. Biology of the interleukin-2 receptor. Adv. Immunol. 70 (1998) 1-81
32. Sherr C.J. Cancer cell cycles. Science 274 (1996) 1672-1677
33. Toyoshima H., and Hunter T. p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21. Cell 78 (1994) 67-74
34. Nourse J., Firpo E., Flanagan W.M., Coats S., Polyak K., Lee M.H., Massague J., Crabtree G.R., and Roberts J.M. Interleukin-2-mediated elimination of the p27Kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372 (1994) 570-573
35. Lu M., Dou Q.P., Kitson R.P., Smith D.M., and Goldfarb R.H. Differential effects of proteasome inhibitors on cell cycle and apoptotic pathways in human YT and Jurkat cells. J. Cell. Biochem. 97 (2006) 122-134
36. He X.S., Draghi M., Mahmood K., Holmes T.H., Kemble G.W., Dekker C.L., Arvin A.M., Parham P., and Greenberg H.B. T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. J. Clin. Invest. 114 (2004) 1812-1819
37. McDyer J.F., Li Z., John S., Yu X., Wu C.Y., and Ragheb J.A. IL-2 receptor blockade inhibits late, but not early, IFN-gamma and CD40 ligand expression in human T cells: disruption of both IL-12-dependent and -independent pathways of IFN-gamma production. J. Immunol. 169 (2002) 2736-2746
38. Yu A., and Malek T.R. The proteasome regulates receptor-mediated endocytosis of interleukin-2. J. Biol. Chem. 276 (2001) 381-385
39. Yu C.L., and Burakoff S.J. Involvement of proteasomes in regulating Jak-STAT pathways upon interleukin-2 stimulation. J. Biol. Chem. 272 (1997) 14017-14020
40. Shim J.H., Choi H.S., Pugliese A., Lee S.Y., Chae J.I., Choi B.Y., Bode A.M., and Dong Z. (-)-Epigallocatechin gallate regulates CD3-mediated T cell receptor signaling in leukemia through the inhibition of ZAP-70 kinase. J. Biol. Chem. 283 (2008) 28370-28379
41. Haslam E. Natural polyphenols (vegetable tannins) as drugs: possible modes of action. J. Nat. Prod. 59 (1996) 205-215
42. Shimamura T., Zhao W.-H., and Hu Z.-Q. Mechanism of action and potential for use of tea catechin as an antiinfectiveagent. Anti-Infect. Agents Med. Chem. 6 (2007) 57-62
43. Fischer A., Pallauf J., Gohil K., Weber S.U., Packer L., and Rimbach G. Effect of selenium and vitamin E deficiency on differential gene expression in rat liver. Biochem. Biophys. Res. Commun. 285 (2001) 470-475
44. Han S.N., Adolfsson O., Lee C.K., Prolla T.A., Ordovas J., and Meydani S.N. Age and vitamin E-induced changes in gene expression profiles of T cells. J. Immunol. 177 (2006) 6052-6061